Article
A polymorphism in the CYP17 gene increases the risk of breast cancer.
Cancer research - 15 Mar 1997
Feigelson H S, Coetzee G A, Kolonel L N, Ross R K, Henderson B E
Abstract excerpt
We conducted a case-control study to determine whether a polymorphism in the CYP17 gene was associated with risk of breast cancer. We found an increased risk of advanced breast cancer in women carrying an A2 allele. The odds ratio was 2.5 [95% confidence interval (CI), 1.07-5.94] for regional or...
Topics
Join the communities discussing this publication.
